Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

5.270 -0.060 (-1.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 248,659
Open 5.280
Bid (Size) 5.080 (2)
Ask (Size) 5.700 (32)
Prev. Close 5.330
Today's Range 5.160 - 5.479
52wk Range 2.680 - 8.221
Shares Outstanding 31,399,667
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Capricor Therapeutics Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga

Performance

YTD
+2.93%
+2.93%
1 Month
-25.72%
-25.72%
3 Month
+29.48%
+29.48%
6 Month
+86.88%
+86.88%
1 Year
+34.78%
+34.78%

More News

Read More
Capricor Therapeutics's Earnings Outlook
Via Benzinga
Preview: Capricor Therapeutics's Earnings
Via Benzinga
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Turn Lower; Dow Tumbles Over 200 Points
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Capricor Therapeutics Q1 Earnings
Via Benzinga
Earnings Preview For Capricor Therapeutics
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
Via Benzinga
Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study
Via Benzinga
Earnings Scheduled For March 15, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
Via Benzinga
Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
Via Benzinga
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
Via Benzinga
7 Undervalued Penny Stocks With Major Upside
Via InvestorPlace
50 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.